The Safety and Efficacy of Deferoxamine for Treating Unresectable Hepatocellular Carcinoma

NCT03652467 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma Non-resectable

Interventions

DRUG: Conventional TACE
DRUG: Deferoxamine and conventional TACE

Sponsor

Jinan Military General Hospital